Myo-inositol 1,3,4,5_tetrakisphosphate [Ins(1,3,4,5)P,] acts as a full agonist for Ca" release in saponin-permeabilised SH-SYSY neuroblastoma cells. Studies were conducted in the presence of myo-inositol hexakisphosphate (InsP,, 10 BUM), to inhibit the Ins( 1,3,4,5)P,-3-phosphatase catalysed back conversion of Ins(l,3,4,5)P, to Ins(lfl,S)P,. HPLC anaiysis confirmed that Ins(l,3,4,5)P, releases the entire content of Ins(l,4,5)P,-sensitive intra~Ilular Ca2* stores, independent of 3-phosphate activity. Further we utilised racemic myo-inositoll,4,5-t~sphosphat~3-phosphorothioate [m-Ins(l,3,4,5)P,-3S], a novel intrinsically Ins(l,3,4,5)P~-3-phosphatase resistant Ins(l,3,4,5)P, analogue. DL-Ins(1 ,3,4,5)P,-3S specifically displaced ['H]Ins(l,4,5)P, from bovine adrenal cortex Ins(1,4,5)P, binding sites (IC,, = 889 nM, compared to Ins(1,4,5)P,, ICs, = 4.4 nM and Ins(1,3,4,5)P,, I&, = 152 nM). m.-Ins(l,3,4,5)P,-3S was a full agonist for Ca2' release (EC% = 4.7 PM), being 90-and 2-fold less potent than Ins(1,4,5)P, and Ins(l,3,4,5)P, (with InsP,), respectively. DL-Ins( 1,3,4,5)P.,-3S will be an important tool for identification of potentially exclusive Ins(l,3,4,5)P., second messenger functions, since its resistance to 3-phosphatase action precludes the inconvenient artefact of steady state Ins(1,4,5)P, generation.